One platform for Commercialization
Our end-to-end software platform, ATAS, addresses all of the critical challenges in bringing personalized therapies to market while integrating seamlessly into therapy workflows:
Chain of Identity and Custody
Billing and Reimbursement
Our data analytics engine will also power insights to optimize from end to end.
The ATAS platform is system-agnostic and fully configurable, and we safeguard all of our customer’s proprietary information.
We have assembled a leading team of commercial cell therapy experts, software engineers, designers, regulatory experts, and scientists. Vitruvian Networks is uniquely positioned to help customers navigate the technical and regulatory complexities of successfully bringing personalized therapies to market.
Join our Team